AstraZeneca’s press release announces that the FDA has approved Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) as the first and only single‑inhaler triple‑combination maintenance therapy for asthma in patients 12 years and older[…]
The Asthma and Allergy Foundation of America (AAFA) has published a new resource: “Health Insurance Marketplace Guide for Asthma and Allergies for 2026.” This comprehensive guide is designed to help[…]
Looking to help yourself or others quit tobacco for good? The Michigan Department of Health and Human Services (MDHHS) Tobacco Cessation Toolkit offers comprehensive resources for individuals and organizations supporting[…]
The 2026 Global Initiative for Chronic Obstructive Lung Disease (GOLD) Report and Pocket Guide is an internationally recognized resources that outlines evidence-based strategies for the diagnosis, management, and prevention of[…]